Aberdeen Group’s Arrowhead Research ARWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.5M Sell
251,968
-112,004
-31% -$8.27M 0.03% 437
2026
Q1
$22.8M Buy
363,972
+77,826
+27% +$4.93M 0.04% 389
2025
Q4
$19M Sell
286,146
-234,498
-45% -$11.5M 0.03% 453
2025
Q3
$18M Sell
520,644
-439,601
-46% -$9.66M 0.03% 467
2025
Q2
$15.2M Sell
960,245
-112,582
-10% -$1.62M 0.03% 487
2025
Q1
$13.7M Buy
1,072,827
+622,752
+138% +$11.3M 0.03% 489
2024
Q4
$8.46M Buy
450,075
+48,929
+12% +$1.01M 0.02% 541
2024
Q3
$7.77M Buy
401,146
+152,476
+61% +$3.72M 0.01% 569
2024
Q2
$6.46M Buy
+248,670
New +$6.11M 0.01% 586

Other funds holding ARWR

Aberdeen Group's ARWR Position: Q2 2026 in Review

Aberdeen Group reduced its Arrowhead Research (ARWR) stake by 31% in Q2 2026, selling an estimated $8.27M and leaving 251,968 shares worth $20.5M. The position accounts for 0.03% of the portfolio, ranked #437.

Aberdeen Group first reported a position in ARWR in Q2 2024 and has held it in 9 quarters since. The position peaked at $22.8M in Q1 2026. 500 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.

  • Aberdeen Group held 251,968 shares of Arrowhead Research worth $20.5M as of Q2 2026.
  • Aberdeen Group sold 112,004 Arrowhead Research shares in Q2 2026, an estimated $8.27M.
  • Arrowhead Research made up 0.03% of Aberdeen Group's portfolio in Q2 2026, its #437 holding.
  • Aberdeen Group first reported a position in Arrowhead Research in Q2 2024 and has held it in 9 quarters since.
  • Aberdeen Group's Arrowhead Research position peaked at $22.8M in Q1 2026.
  • 500 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.